Basking Ridge, NJ13 Active Studies

Osteogenesis Imperfecta Clinical Trials in Basking Ridge, NJ

Find 13 actively recruiting osteogenesis imperfecta clinical trials in Basking Ridge, NJ. Connect with local research sites and explore new treatment options.

13
Active Trials
1
Sponsors
764
Enrolling

Recruiting Osteogenesis Imperfecta Studies in Basking Ridge

About Osteogenesis Imperfecta Clinical Trials in Basking Ridge

Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.

There are currently 13 osteogenesis imperfecta clinical trials recruiting participants in Basking Ridge, NJ. These studies are seeking a combined 764 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Osteogenesis Imperfecta Clinical Trials in Basking Ridge — FAQ

Are there osteogenesis imperfecta clinical trials in Basking Ridge?

Yes, there are 13 osteogenesis imperfecta clinical trials currently recruiting in Basking Ridge, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Basking Ridge?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Basking Ridge research site will contact you about next steps.

Are clinical trials in Basking Ridge free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Basking Ridge studies also compensate for your time and travel.

What osteogenesis imperfecta treatments are being tested?

The 13 active trials in Basking Ridge are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.

Data updated July 17, 2026 from ClinicalTrials.gov